一例罕见的同步性多原发性肺癌对吉非替尼有不同反应的病例。
A rare case of synchronous multiple primary lung cancer with different responses to gefitinib.
作者信息
Liao Che-Chi, Lin Yu-Sen, Lin Yu-Chao, Cheng Chiao-Jen, Chen Shuo-Chueh
机构信息
Department of Internal Medicine, China Medical University Hospital, Taichung, 404, Taiwan.
Graduate Institute of Clinical Medical Science, China Medical University, Taichung, 404, Taiwan.
出版信息
Respir Med Case Rep. 2020 Oct 24;31:101270. doi: 10.1016/j.rmcr.2020.101270. eCollection 2020.
Abstract
Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.
摘要
区分多原发性肺癌（MPLC）与肺转移瘤很重要，而且不同肿瘤之间的病理和基因突变可能存在差异。应考虑进行肺活检以鉴别病变，尤其是当不同肿瘤对治疗的反应不同时。
Zotero 插件